Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTREPiD: Rapid Malaria Testing in Early Pregnancy
NCT05757167Phase 4Active, not recruiting
- Sponsor
- Duke University
- Start
- Nov 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of artemether + lumefantrine in malaria, sponsored by Duke University. Started Nov 2023; status: active, not recruiting.
02
Drugs
artemether + lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT05757167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05757167.